MicrobiotaNCT02049398
Study of Variation Over Time in the Oral Microbiome
An observational study of Microbiota and Oral Health, run by National Cancer Institute (NCI) at 1 site in United States.
Trial summary
Background: Normal bacteria and other tiny organisms are found in healthy human mouths. These are called oral microbiota. It is unclear exactly how the oral microbiota may affect health. For example, if the microbial composition is abnormal, it may lead to mouth conditions like periodontitis. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Microbiota, Oral Health, Body Mass Index
- Type of treatment
- Pill or oral medicine
- How many people
- 41 participants
- Where
- 1 siteUnited States
- Study dates
- 28 Jan 2014to 23 Dec 2015
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Employees of the National Cancer Institute.
- Everyone who plans to continue working at the NCI for at least a year is eligible to participate.
Trial locations and contacts
1 site in 1 country.
United States1 site
National Cancer Institute (NCI), 9000 Rockville Pike
Bethesda, Maryland, 20892
About this study
Official title: Temporal Variation In The Oral Microbiome
Background:
- Normal bacteria and other tiny organisms are found in healthy human mouths. These are called oral microbiota. It is unclear exactly how the oral microbiota may affect health. For example, if the microbial composition is abnormal, it may lead to mouth conditions like periodontitis. Researchers want to study how the microbiota changes over time. This can help them plan future disease studies.
Read more
Objectives:
- To see if and how oral microbiota change over time.
Eligibility:
- Forty adult employees of the National Cancer Institute Shady Grove.
Design:
- For 12 hours before the first visit, participants will not eat or drink (except water). They will not brush, floss, use mouthwash, chew gum, eat lozenges or candies, smoke cigarettes, or chew tobacco.
- At the first visit, participants will:
- Be given a saliva collector. They will spit 2 mL of saliva into it.
- Fill out an online questionnaire.
- Every 2 months, participants will visit the clinic and repeat visit 1.
- The study ends after 1 year.
Sponsoring Institute: National Cancer Institute
Read the detailed description
The Human Microbiome Project (HMP), started in 2008, aimed to characterize the microbial communities on the skin, in the oral and nasal cavities, and in the gastrointestinal and urogenital tracts. This project cross-sectionally described the microbial communities in a healthy human population, but did not adequately describe longitudinal stability. Out of the 236 adults included in the HMP, a second saliva sample was collected on a small subset (N=74) with a long interval between collections, an average of 203 days. Community similarity was calculated between two visits; for saliva samples, the Spearman correlation was high (rs=0.8). However, it was unclear which metric of community similarly was being used for this calculation. When we obtained the HMP data and calculated the Spearman correlation for specific diversity metrics in the saliva samples, the correlations were weaker and ranged from 0.225 to 0.524 for the Shannon Index and PD tree, respectively. Other studies with fewer people, but more time points, have had conflicting conclusions on the temporal variation of the oral microbiome. Given this variability, it is vital to establish whether a single measurement is representative of the typical composition of microbiota in a specific body site using more than two time points.
In epidemiological studies, it is often impractical, if not impossible, to collect biological samples or measurements multiple times for each participant during the study period. However, when a biological sample or a measurement is taken only once, there is concern that the single assessment is not representative of the typical value. For example, serum 25(OH)D levels, which are used to assess an individual s vitamin D exposure, have seasonal fluctuations, but studies have established that a single measurement is sufficiently reliable to represent typical exposure. The correlation between samples over time is also used to create more accurate power calculations for future studies.
Since previous work has not adequately addressed temporal variation in the oral microbiome, we propose to: 1) establish a cohort of 40 adults willing to provide oral samples approximately every two months for one year; 2) process all oral samples and evaluate the presence and quantity of microbiota using 16S ribosomal RNA gene sequencing; 3) calculate appropriate reliability measures for the sample over time using the intra-class correlation coefficient (ICC) for and <= diversity metrics; and 4) empirically evaluate the efficiency of different longitudinal designs including two or more sample collections with an outcome such as body mass index (BMI). Because of the complexity and high prevalence of human DNA in saliva, metagenomic analyses of oral samples are not yet feasible, however, the samples obtained from this study will be available for use in future metagenomic analyses when the technology is operationalized. The current study is essential to establish the reliability of a single measure of the oral microbiome to determine appropriate sample sizes for future cohort studies considering the effect of the oral microbiome on the risk of cancer and other health outcomes.
- Conditions
- Microbiota, Oral Health, Body Mass Index
- Keywords
- Microbiome, Saliva, Reliability, Oral Cavity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Oral microbiome cohort | a cohort of 40 adults willing to provide oral samples approximately every two months forone year |
What is being measured
The primary outcome is the main question the study is designed to answer.
Intraclass correlation coefficient for alpha/beta diversity measures.
Stability of oral microbiome over 10 months
Measured: 10 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Jan 2014 (estimated)
- Study start28 Jan 2014
- Primary completion16 Sep 2015
- Study completion23 Dec 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for MicrobiotaStudies of the same condition, open and under way.
- More trials run by National Cancer Institute (NCI)The sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 41 participants (actual)
Sponsor and investigators
- Lead sponsor
- National Cancer Institute (NCI)
- Sponsor type
- US National Institutes of Health
- Responsible party
- Sponsor
- Investigators
- Christian Abnet, Ph.D., Principal investigator, National Cancer Institute (NCI)
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02049398
- Sponsor's protocol ID
- 999914047
- Other IDs
- 14-C-N047
- Status last verified
- Nov 2020
- First submitted
- 28 Jan 2014
- Last updated
- 27 Nov 2020
- Results posted
- No
Publications
Zhou Y, Gao H, Mihindukulasuriya KA, La Rosa PS, Wylie KM, Vishnivetskaya T, Podar M, Warner B, Tarr PI, Nelson DE, Fortenberry JD, Holland MJ, Burr SE, Shannon WD, Sodergren E, Weinstock GM. Biogeography of the ecosystems of the healthy human body. Genome Biol. 2013 Jan 14;14(1):R1. doi: 10.1186/gb-2013-14-1-r1.
PubMed 23316946Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science. 2009 Dec 18;326(5960):1694-7. doi: 10.1126/science.1177486. Epub 2009 Nov 5.
PubMed 19892944Lazarevic V, Whiteson K, Hernandez D, Francois P, Schrenzel J. Study of inter- and intra-individual variations in the salivary microbiota. BMC Genomics. 2010 Sep 28;11:523. doi: 10.1186/1471-2164-11-523.
PubMed 20920195
Study at a glance
From the registry record, last updated by the sponsor on 27 Nov 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Temporal Variation In The Oral Microbiome
- ClinicalTrials.gov ID
- NCT02049398
- Acronym / sponsor ID
- 999914047
- Conditions
- Microbiota, Oral Health, Body Mass Index
- Keywords
- Microbiome, Saliva, Reliability, Oral Cavity
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 41 participants (actual)
- Lead sponsor
- National Cancer Institute (NCI)US National Institutes of Health
- Study start
- 28 Jan 2014 (actual)
- Primary completion
- 16 Sep 2015 (actual)
- Study completion
- 23 Dec 2015 (actual)
- First posted
- 30 Jan 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background:
- Normal bacteria and other tiny organisms are found in healthy human mouths. These are called oral microbiota. It is unclear exactly how the oral microbiota may affect health. For example, if the microbial composition is abnormal, it may lead to mouth conditions like periodontitis. Researchers want to study how the microbiota changes over time. This can help them plan future disease studies.
Objectives:
- To see if and how oral microbiota change over time.
Eligibility:
- Forty adult employees of the National Cancer Institute Shady Grove.
Design:
- For 12 hours before the first visit, participants will not eat or drink (except water). They will not brush, floss, use mouthwash, chew gum, eat lozenges or candies, smoke cigarettes, or chew tobacco.
- At the first visit, participants will:
- Be given a saliva collector. They will spit 2 mL of saliva into it.
- Fill out an online questionnaire.
- Every 2 months, participants will visit the clinic and repeat visit 1.
- The study ends after 1 year.
Sponsoring Institute: National Cancer Institute
Detailed description
The Human Microbiome Project (HMP), started in 2008, aimed to characterize the microbial communities on the skin, in the oral and nasal cavities, and in the gastrointestinal and urogenital tracts. This project cross-sectionally described the microbial communities in a healthy human population, but did not adequately describe longitudinal stability. Out of the 236 adults included in the HMP, a second saliva sample was collected on a small subset (N=74) with a long interval between collections, an average of 203 days. Community similarity was calculated between two visits; for saliva samples, the Spearman correlation was high (rs=0.8). However, it was unclear which metric of community similarly was being used for this calculation. When we obtained the HMP data and calculated the Spearman correlation for specific diversity metrics in the saliva samples, the correlations were weaker and ranged from 0.225 to 0.524 for the Shannon Index and PD tree, respectively. Other studies with fewer people, but more time points, have had conflicting conclusions on the temporal variation of the oral microbiome. Given this variability, it is vital to establish whether a single measurement is representative of the typical composition of microbiota in a specific body site using more than two time points.
In epidemiological studies, it is often impractical, if not impossible, to collect biological samples or measurements multiple times for each participant during the study period. However, when a biological sample or a measurement is taken only once, there is concern that the single assessment is not representative of the typical value. For example, serum 25(OH)D levels, which are used to assess an individual s vitamin D exposure, have seasonal fluctuations, but studies have established that a single measurement is sufficiently reliable to represent typical exposure. The correlation between samples over time is also used to create more accurate power calculations for future studies.
Since previous work has not adequately addressed temporal variation in the oral microbiome, we propose to: 1) establish a cohort of 40 adults willing to provide oral samples approximately every two months for one year; 2) process all oral samples and evaluate the presence and quantity of microbiota using 16S ribosomal RNA gene sequencing; 3) calculate appropriate reliability measures for the sample over time using the intra-class correlation coefficient (ICC) for and <= diversity metrics; and 4) empirically evaluate the efficiency of different longitudinal designs including two or more sample collections with an outcome such as body mass index (BMI). Because of the complexity and high prevalence of human DNA in saliva, metagenomic analyses of oral samples are not yet feasible, however, the samples obtained from this study will be available for use in future metagenomic analyses when the technology is operationalized. The current study is essential to establish the reliability of a single measure of the oral microbiome to determine appropriate sample sizes for future cohort studies considering the effect of the oral microbiome on the risk of cancer and other health outcomes.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Oral microbiome cohort | – | –a cohort of 40 adults willing to provide oral samples approximately every two months forone year |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Employees of the National Cancer Institute.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Intraclass correlation coefficient for alpha/beta diversity measures.
Time frame: 10 months
Stability of oral microbiome over 10 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Nov 2020.
- Background: PubMed 23316946Zhou Y, Gao H, Mihindukulasuriya KA, La Rosa PS, Wylie KM, Vishnivetskaya T, Podar M, Warner B, Tarr PI, Nelson DE, Fortenberry JD, Holland MJ, Burr SE, Shannon WD, Sodergren E, Weinstock GM. Biogeography of the ecosystems of the healthy human body. Genome Biol. 2013 Jan 14;14(1):R1. doi: 10.1186/gb-2013-14-1-r1.
- Background: PubMed 19892944Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science. 2009 Dec 18;326(5960):1694-7. doi: 10.1126/science.1177486. Epub 2009 Nov 5.
- Background: PubMed 20920195Lazarevic V, Whiteson K, Hernandez D, Francois P, Schrenzel J. Study of inter- and intra-individual variations in the salivary microbiota. BMC Genomics. 2010 Sep 28;11:523. doi: 10.1186/1471-2164-11-523.
Related trials for Microbiota
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
Active, not recruitingPhase 2
Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT)
Multi-Drug Resistant Organism Colonization
Recruiting
The Effect of a Synbiotic on Intestinal Barrier Function and Microbiota Modulation in Middle-aged to Elderly Individuals
Gastrointestinal Microbiome (Focus), Gastrointestinal Symptoms
RecruitingObservational study
Westlake Aging Cohort (WeAC)
Aging, Cognition Improvement
Not yet recruiting
Tumoral Versus Luminal Microbiome in Head and Neck Squamous Cell Carcinoma
Squamous Cell Cancer of Head and Neck (SCCHN)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Christian Abnet, Ph.D. principal investigator
National Cancer Institute (NCI)
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Microbiota and Oral Health, run by National Cancer Institute (NCI) at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Intraclass correlation coefficient for alpha/beta diversity measures. (time frame: 10 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02049398, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Nov 2020.